© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
June 25, 2021
Santen Inc. announced Thursday that the U.S. FDA has approved Verkazia (cyclosporine ophthalmic emulsion) 0.1% eye drops to treat vernal keratoconjunctivitis (VKC).
June 22, 2021
According to investigators, the system has been shown to almost triple the number of people with eye problems attending primary care, as well as increasing appropriate uptake of hospital services.
June 17, 2021
The event, being held at the Mandalay Bay Resort and Casino in Las Vegas, is offering a full agenda for in-person attendees.
June 14, 2021
EyeGate Pharmaceuticals, Inc.'s lead product candidate is designed to treat dry eye disease-induced ocular surface inflammation.
May 19, 2021
Delivering existing therapeutics through alternative routes may offer option.
March 02, 2021
Autologous serum eye drops and blood products offer hope to patients.
February 18, 2021
Growing patient pool is driving clinical trial investment.
January 25, 2021
Ocular symptoms in COVID-19 patients may be more common than previously thought — with sore eyes a significant sign of disease.
July 10, 2020
First new therapy in nearly a decade offers another option for physicians, patients
March 01, 2019
Study and use of platelet preparation, other biologics viewed as next frontier
